Cargando…
Association between genetic polymorphisms in cytochrome P450 enzymes and survivals in women with breast cancer receiving adjuvant endocrine therapy: a systematic review and meta-analysis
Tamoxifen is commonly prescribed for preventing recurrence in patients with breast cancer. However, the responses of the patients on tamoxifen treatment are variable. Cytochrome P450 genetic variants have been reported to have a significant impact on the clinical outcomes of tamoxifen treatment but...
Autores principales: | Chan, Carmen Wing Han, Li, Caixia, Xiao, Eleven Jinnan, Li, Minjie, Phiri, Patrick Gladson McLeywick, Yan, Tingting, Chan, Judy Yuet Wa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9884795/ https://www.ncbi.nlm.nih.gov/pubmed/34991754 http://dx.doi.org/10.1017/erm.2021.28 |
Ejemplares similares
-
Tamoxifen-related endocrine symptoms in Chinese patients with breast cancer: Study protocol clinical trial (SPIRIT Compliant)
por: Chan, Carmen Wing Han, et al.
Publicado: (2020) -
The Cytochrome P450 Homepage
por: Nelson, David R
Publicado: (2009) -
Probing the Role of the Hinge Segment of Cytochrome P450 Oxidoreductase in the Interaction with Cytochrome P450
por: Campelo, Diana, et al.
Publicado: (2018) -
Correlation of Cytochrome P450 Oxidoreductase Expression with the
Expression of 10 Isoforms of Cytochrome P450 in Human Liver
por: Zhang, Hai-Feng, et al.
Publicado: (2016) -
The FMN “140s Loop” of Cytochrome P450 Reductase Controls Electron Transfer to Cytochrome P450
por: Rwere, Freeborn, et al.
Publicado: (2021)